Talk to us?

NEET MDS Synopsis - Lecture Notes
Practice Subscribe 👤 Welcome User

📖 Periodontology

Showing page 1 of 15 (58 total records)
Progression from Gingivitis to Periodontitis
Periodontology

Progression from Gingivitis to Periodontitis

The transition from gingivitis to periodontitis is a critical process in periodontal disease progression. This lecture will outline the key stages involved in this progression, highlighting the changes in microbial composition, host response, and tissue alterations.

Pathway of Progression

  1. Establishment and Maturation of Supragingival Plaque:

    • The process begins with the formation of supragingival plaque, which is evident in gingivitis.
    • As this plaque matures, it becomes more complex and can lead to changes in the surrounding tissues.

  2. Migration of Periodontopathogenic Bacteria:

    • When the microbial load overwhelms the local host immune response, pathogenic bacteria migrate subgingivally (below the gum line).
    • This migration establishes a subgingival niche that is conducive to the growth of periodontopathogenic bacteria.

Initial Lesion

  • Timeline:
    • The initial lesion, characterized by subclinical gingivitis, appears approximately 2 to 4 days after the colonization of the gingival sulcus by bacteria.
  • Clinical Manifestations:
    • Vasculitis: Inflammation of blood vessels in the gingival tissue.
    • Exudation of Serous Fluid: Increased flow of gingival crevicular fluid (GCF) from the gingival sulcus.
    • Increased PMN Migration: Polymorphonuclear neutrophils (PMNs) migrate into the sulcus in response to the inflammatory process.
    • Alteration of Junctional Epithelium: Changes occur at the base of the pocket, affecting the integrity of the junctional epithelium.
    • Collagen Dissolution: Perivascular collagen begins to dissolve, contributing to tissue breakdown.

Early Lesion

  • Timeline:
    • The early lesion forms within 4 to 7 days after the initial lesion due to the continued accumulation of bacterial plaque.
  • Characteristics:
    • Leukocyte Accumulation: There is a significant increase in leukocytes at the site of acute inflammation, indicating an ongoing immune response.
    • Cytopathic Alterations: Resident fibroblasts undergo cytopathic changes, affecting their function and viability.
    • Collagen Loss: Increased collagen loss occurs within the marginal gingiva, contributing to tissue destruction.
    • Proliferation of Basal Cells: The basal cells of the junctional epithelium proliferate in response to the inflammatory environment.
Periodontal Medicaments
Periodontology

Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues. This lecture will discuss several periodontal medicaments, their compositions, and their clinical applications.

1. Elyzol

  • Composition:
    • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
  • Clinical Use:
    • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
    • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

  • Composition:

    • Actisite consists of tetracycline-containing fibers.
    • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.

  • Clinical Use:

    • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

  • Composition:

    • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.

  • Clinical Use:

    • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

  • Composition:

    • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.

  • Clinical Use:

    • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

  • Composition:

    • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.

  • Clinical Use:

    • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

  • Composition:

    • Periochip is a biodegradable chip that contains chlorhexidine.

  • Clinical Use:

    • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.
Periodontal Medications
Periodontology

Periodontal Medications and Their Uses

Periodontal medications play a crucial role in the management of periodontal diseases, aiding in the treatment of infections, inflammation, and tissue regeneration. Understanding the various types of medications and their specific uses is essential for effective periodontal therapy.

Types of Periodontal Medications

  1. Antibiotics:

    • Uses:
      • Used to treat bacterial infections associated with periodontal disease.
      • Commonly prescribed antibiotics include amoxicillin, metronidazole, and doxycycline.
    • Mechanism:
      • They help reduce the bacterial load in periodontal pockets, promoting healing and reducing inflammation.

  2. Antimicrobial Agents:

    • Chlorhexidine:
      • Uses: A topical antiseptic used as a mouth rinse to reduce plaque and gingivitis.
      • Mechanism: It disrupts bacterial cell membranes and inhibits bacterial growth.
    • Tetracycline:
      • Uses: Can be used topically in periodontal pockets to reduce bacteria.
      • Mechanism: Inhibits protein synthesis in bacteria, reducing their ability to cause infection.

  3. Anti-Inflammatory Medications:

    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
      • Uses: Used to manage pain and inflammation associated with periodontal disease.
      • Examples: Ibuprofen and naproxen.
    • Corticosteroids:
      • Uses: May be used in severe cases to reduce inflammation.
      • Mechanism: Suppress the immune response and reduce inflammation.

  4. Local Delivery Systems:

    • Doxycycline Gel (Atridox):
      • Uses: A biodegradable gel that releases doxycycline directly into periodontal pockets.
      • Mechanism: Provides localized antibiotic therapy to reduce bacteria and inflammation.
    • Minocycline Microspheres (Arestin):
      • Uses: A localized antibiotic treatment that is placed directly into periodontal pockets.
      • Mechanism: Releases minocycline over time to combat infection.

  5. Regenerative Agents:

    • Bone Grafts and Guided Tissue Regeneration (GTR) Materials:
      • Uses: Used in surgical procedures to promote the regeneration of lost periodontal tissues.
      • Mechanism: Provide a scaffold for new tissue growth and prevent the ingrowth of epithelium into the defect.

  6. Desensitizing Agents:

    • Fluoride Varnishes:
      • Uses: Applied to sensitive areas to reduce sensitivity and promote remineralization.
      • Mechanism: Strengthens enamel and reduces sensitivity by occluding dentinal tubules.

Clinical Significance of Periodontal Medications

  1. Management of Periodontal Disease:

    • Medications are essential in controlling infections and inflammation, which are critical for the successful treatment of periodontal diseases.

  2. Adjunct to Non-Surgical Therapy:

    • Periodontal medications can enhance the effectiveness of non-surgical treatments, such as scaling and root planing, by reducing bacterial load and inflammation.

  3. Surgical Interventions:

    • In surgical procedures, medications can aid in healing and regeneration, improving outcomes for patients undergoing periodontal surgery.

  4. Patient Compliance:

    • Educating patients about the importance of medications in their treatment plan can improve compliance and overall treatment success.
Keratinized Gingiva and Attached Gingiva
Periodontology

Keratinized Gingiva and Attached Gingiva

The gingiva is an essential component of the periodontal tissues, providing support and protection for the teeth. Understanding the characteristics of keratinized gingiva, particularly attached gingiva, is crucial for assessing periodontal health.

Keratinized Gingiva

  1. Definition:

    • Keratinized gingiva refers to the gingival tissue that is covered by a layer of keratinized epithelium, providing a protective barrier against mechanical and microbial insults.

  2. Areas of Keratinized Gingiva:

    • Attached Gingiva:
      • Extends from the gingival groove to the mucogingival junction.
    • Marginal Gingiva:
      • The free gingival margin that surrounds the teeth.
    • Hard Palate:
      • The roof of the mouth, which is also covered by keratinized tissue.

Attached Gingiva

  1. Location:

    • The attached gingiva is the portion of the gingiva that is firmly bound to the underlying alveolar bone.

  2. Width of Attached Gingiva:

    • The width of attached gingiva varies based on location and can increase with age and in cases of supraerupted teeth.

  3. Measurements:

    • Greatest Width:
      • Found in the incisor region:
        • Maxilla: 3.5 mm - 4.5 mm
        • Mandible: 3.3 mm - 3.9 mm
    • Narrowest Width:
      • Found in the posterior region:
        • Maxillary First Premolar: 1.9 mm
        • Mandibular First Premolar: 1.8 mm

Clinical Significance

  • Importance of Attached Gingiva:

    • The width of attached gingiva is important for periodontal health, as it provides a buffer zone against mechanical forces and helps maintain the integrity of the periodontal attachment.
    • Insufficient attached gingiva may lead to increased susceptibility to periodontal disease and gingival recession.

  • Assessment:

    • Regular assessment of the width of attached gingiva is essential during periodontal examinations to identify potential areas of concern and to plan appropriate treatment strategies.